Collectively, our findings provide novel molecular insights on how lipid is aberrantly accumulated in the liver, and highlight critical protective roles that CRTC1 selectively plays against NAFLD development. This evidence concerns the gene CRTC1 and metabolic dysfunction-associated steatotic liver disease.